Anika Therapeutics | ANIK - Market Capitalization

Stock Price
14.56
Daily Change
0.28 1.96%
Monthly
13.84%
Yearly
-3.96%
Q1 Forecast
13.43

Anika Therapeutics reported $213M in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 217.86B 15.25B Dec/2025
Agenus USD 1.66B 1.55B Mar/2026
Agios Pharmaceuticals USD 1.59B 745M Dec/2025
Anika Therapeutics USD 210M 71M Mar/2026
Arrowhead Research USD 9.02B 4.25B Dec/2025
Enanta Pharmaceuticals USD 122M 98M Dec/2024
Halozyme Therapeutics USD 7.91B 664M Dec/2025
Heron Therapeutics USD 133M 105M Mar/2026
Insmed USD 37.12B 6.68B Dec/2025
Integra LifeSciences USD 967M 150M Dec/2025
J&J USD 500.24B 67.44B Dec/2025
MacroGenics USD 192M 90M Mar/2026
Merit Medical Systems USD 5.23B 297M Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025
Smith & Nephew USD 3.83B 9.49B Mar/2026
Stryker USD 134.41B 6.92B Dec/2025
Veracyte USD 3.33B 627M Dec/2025
Xencor USD 1.09B 256M Dec/2025
Zimmer Biomet Holdings USD 17.82B 1.69B Dec/2025